Safety and Clinical Effectiveness of Intravitreal Bevacizumab (Lumiere®) in Patients With Wet Age-related Macular Degeneration (Wet AMD)

NCT03668054 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: Bevacizumab (Lumiere®)

Sponsor

Laboratorio Elea Phoenix S.A.